Work

Editorial: TIPS in the Era of Aging and Metabolic Comorbidity: Rethinking Risks and Rewards

Year: 2026

Type: editorial

Abstract: The transjugular intrahepatic portosystemic shunt (TIPS) represents a key intervention for portal hypertension (PH) complications. However, the epidemiology of chronic liver disease has changed substantially, with diabetes, obesity, and metabolic dysfunction–associated steatotic liver disease (MASLD) now representing the leading etiologies [1]. In this evolving context, TIPS indications and outcomes must be carefully reassessed.

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/apt.70496

Authors: Davide Roccarina, Rosario La Delfa, Francesco Vizzutti

Institutions: The Royal Free Hospital, University of Florence, University College London, Azienda Ospedaliero-Universitaria Careggi

Language: English

Topic: Liver Disease and Transplantation

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Università degli Studi di Firenze

OpenAlex ID: W7124422613

Cites: 9

Cited by: 1

Related to: